ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 483

Non-Steroidal Anti-Inflammatory Drugs Are More Beneficial Than Anti-Tnfα Drugs on the Radiographic Damage in Arthritis: A Study in Adjuvant Induced Arthritis

Frank Verhoeven1, Clément Prati2, Perle Totoson1, Romani Bordy3, Daniel Wendling4 and Céline Demougeot1, 1EA 4267 FDE, FHU INCREASE, Université de Bourgogne Franche-Comté, Besançon, France, 2FDE EA4267, FHU INCREASE, Bourgogne Franche-Comté University, Besançon, France, 3EA 4267 FDE, FHU increase, BESANCON, France, 4Service de Rhumatologie, CHU Jean Minjoz, Besancon, France

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: adjuvant arthritis, anti-TNF therapy, nonsteroidal antiinflammatory drugs (NSAIDs) and radiography

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, November 13, 2016

Title: Rheumatoid Arthritis – Animal Models - Poster I

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: The management of the chronic inflammatory rheumatisms has dramatically evolved in the last decade with a concept of “treat to target”. The theory of a window of opportunity with more beneficial effects of an early intensive treatment is supported by several evidences. The positive impact of an early treatment with a TNFα blocker is expected but the place and the interest of non-steroidal anti-inflammatory treatments (NSAIDs) and glucocorticoids is not clear. The aim of this study was to evaluate the radiological outcomes after an early treatment during 21 days by Etanercept, or Naproxene, or Celecoxib, or Prednisone, or Diclofenac or Methotrexate in adjuvant induced arthritis in rats.

Methods: Adjuvant-induced arthritis (AIA) was induced in 6 weeks old male Lewis rats by injection of Mycobacterium butyricum in adjuvant at the basis of the tail. At the onset of arthritis, rats were daily treated with Naproxene (10 mg/kg/d i.p), or Diclofenac (5mg/kg i.p twice a day), or Celecoxib (3 mg/kg/d i.p) or Prednisone (10 mg/kg/d i.p), or Etanercept (10 mg/kg/3 days, s.c.), or Methotrexate (1mg/kg/3 days, s.c.), or saline solution (Vehicle), for 21 days. Arthritic score was daily monitored. At the end of treatment, paws’ radiological exam was performed with a BMA High Resolution Digital X Ray (40mV, 10mA). A score of 0 to 20 was determined for each paw using a grading scale modified from Ackerman et al (1979).

Results: Compared to the Vehicle, all treatments significantly reduced(p<0.001) arthritic score with a reduction of the arthritic score evaluated between 40% (for methotrexate) and 70% (for diclofenac). Compared to the vehicle, the radiographic score was improved by Naproxene, Diclofenac, Celecoxib, Glucocorticoids, Etanercept (p<0.001) but not by methotrexate. Compared to Etanercept, Naproxene and diclofenac showed less radiological structural changes (p<0.01).

Conclusion: Our study demonstrates for the first time that an early treatment with NSAIDs, excluding COX2 selective inhibitor, is more beneficial than Etanercept on the radiological damages in adjuvant induced arthritis. The close efficacy of all drugs on the arthritis score suggests that the beneficial impact of NSAID is not only driven by their impact on the systemic inflammation. NSAIDs should be used during the window of opportunity.


Disclosure: F. Verhoeven, None; C. Prati, None; P. Totoson, None; R. Bordy, None; D. Wendling, None; C. Demougeot, None.

To cite this abstract in AMA style:

Verhoeven F, Prati C, Totoson P, Bordy R, Wendling D, Demougeot C. Non-Steroidal Anti-Inflammatory Drugs Are More Beneficial Than Anti-Tnfα Drugs on the Radiographic Damage in Arthritis: A Study in Adjuvant Induced Arthritis [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/non-steroidal-anti-inflammatory-drugs-are-more-beneficial-than-anti-tnf%ce%b1-drugs-on-the-radiographic-damage-in-arthritis-a-study-in-adjuvant-induced-arthritis/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/non-steroidal-anti-inflammatory-drugs-are-more-beneficial-than-anti-tnf%ce%b1-drugs-on-the-radiographic-damage-in-arthritis-a-study-in-adjuvant-induced-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology